The Norfolk and Norwich University Hospital (NNUH) is a large National Health Service academic teaching hospital in the Norwich Research Park on the western outskirts of Norwich, England.The university hospital replaced the former, Norfolk and Norwich Hospital, which was founded in 1771, and the West Norwich Hospital. The Norfolk and Norwich University Hospital was built under the Private Finance Initiative (PFI), and opened in late 2001: it has 1237 acute beds and offers a wide range of NHS acute health services plus private patient facilities. It is one of the largest hospitals in the United Kingdom in terms of in-patient capacity. The hospital is part of the Norfolk and Norwich University Hospitals NHS Foundation Trust.NNUH was the first new NHS teaching hospital built in England for more than 30 years and the hospital trust is a partner with the University of East Anglia in the delivery of courses. The hospital is a teaching centre for nurses (adult and children's), midwives, doctors, radiographers, therapists and operating department practitioners. It hosts the Norwich GP speciality training scheme...
Introduction Anatomy provides concepts by which form, spatial relationships, and function are brought into context, while radiology extends these concepts into the living. Imaging science asks how biological information is encoded in an imaging signal, converted into a measurement, validated, and used to support therapeutic development and decision-making. Main part This invited review article follows a pathway from disease biology and image acquisition to quantitative phenotypes, imaging biomarkers, endpoints, and surrogates for regulatory drug approval. What can be measured from an image and how meaningful this is depends on factors such as modality, contrast mechanisms, positioning/loading/motion, reconstruction parameters, and standardization. A quantitative output only becomes a biomarker within a prespecified context of use, and a surrogate after appropriate qualification. The successful development of bone mineral density as a surrogate endpoint for fracture risk illustrates that the association with a clinical outcome is insufficient, whilst scalability and predictive validity of treatment benefits across different drug trials and mechanisms are mandatory. Artificial intelligence can accelerate image acquisition, analysis, and discovery, but does not remove the need for transparency and validation. Conclusions Imaging science is not just anatomy displayed from an acquisition. It is a rigorous interdisciplinary science and “art” at the interface of anatomy, physics, radiology, informatics, metrology, statistics, and trials. Its task is to establish when an image-derived signal can be trusted as evidence. With this in mind, imaging biomarkers and surrogate endpoints represent powerful, scalable tools to support clinical programs of modern therapeutic development.
There is conflicting evidence regarding the optimal management strategy for cervical radiculopathy. We conducted a meta-analysis to evaluate the relative effectiveness of nonsurgical treatment and surgical care in adult patients with cervical radiculopathy. We systematically searched PubMed, Embase, and the Cochrane Library to identify randomized controlled trials (RCTs) comparing nonsurgical treatment with surgical treatment. All statistical analyses were performed using RevMan version 5.4. Five RCTs met the inclusion criteria. Surgical treatment significantly improved neck pain (SMD 0.70, 95
Invasive acral Lentiginous Melanoma (ALM) is a distinct subtype of melanoma, primarily affecting non-sun-exposed extremities such as the palms, soles, and nail beds. First described by Reed in 1976. ALM is characterised by lentiginous proliferation of atypical melanocytes along the basal layer of glabrous skin. While “acral melanoma” refers broadly to melanomas arising on acral sites, “acral lentiginous melanoma” specifically denotes this lentiginous subtype. ALM is disproportionately represented among individuals with richly pigmented skin, including Black, Hispanic and Asian populations, in whom it accounts for a higher proportion of melanoma cases than in White populations. Although it represents only 2–3% of all melanomas, ALM carries a poorer prognosis, with five-year melanoma-specific survival rates averaging 80.6%. The pathogenesis of ALM remains incompletely understood. It is not primarily UV-induced but often associated with mechanical stress on weight-bearing or high-friction areas. Recurrent mutations in KIT, NF1, TERT and TP53 are frequently observed, particularly in older and Asian patients, underscoring its distinct molecular profile. Diagnosis is often delayed due to its subtle presentation as irregularly pigmented macules or patches. Histologically, ALM demonstrates lentiginous basal proliferation with dermal invasion. Management typically involves wide local excision, though advanced disease may require lymph node surgery, radiotherapy or systemic therapy. Prognosis is influenced by tumour thickness, ulceration, and sentinel lymph node involvement. Persistent disparities in outcomes highlight the need for improved awareness, earlier diagnosis, and targeted management strategies to address the biological and sociodemographic complexities of ALM.
Background:Lentigo maligna (LM) can be treated surgically, topically using imiquimod, or simply observed. The risk of progression to melanoma is considered low. There is clinical equipoise on management in older or frail adults, with no decision aids available for managing LM in this group. Objectives:To co-design a patient decision aid (PDA) for the management of LM in older or frail adults. Methods:The PDA was targeted at patients at least 85 years old, or those aged 75-84 years with a Rockwood Clinical Frailty Score of at least 4. Semi-structured interviews were conducted with patients and healthcare practitioners (HCPs) to co-design the tool. Thematic analysis was performed using NVivo 14. The prototype was tested via structured interviews with patients and HCPs, and amended in an iterative process until saturation was achieved. Results:In total, 13 patients and 18 HCPs were interviewed to co-design the prototype. Alpha-testing resulted in saturation after 20 iterations. The following key themes (and subthemes) were identified Theme 1: fear of cancer (definition of LM; risk of progression; prognosis); Theme 2: burden of treatment (risks, side effects and delays in treatment; likelihood of recurrence; frequency of follow-up; impact on quality of life); Theme 3: partnership and shared decision-making (empowering patients; involving family and carers; burden of responsibility); and Theme 4: information overload (less is more; accessibility). Conclusions:This is the first PDA for the management of LM in older and frail patients. This co-designed, patient-centred tool may empower patients to participate in decision-making by better understanding LM and the available management options.
Health inequity: defined as systematic and avoidable difference in health outcome, remain entrenched across high-income countries, with socioeconomic gaps in life expectancy exceeding 7–10 years. Upstream interventions addressing the social determinants of health are critical. This umbrella review evaluates which macro-level policies and public health interventions most effectively reduce health inequity. We conducted an umbrella review of systematic reviews. Four databases (Embase, Medline, Scopus, Cochrane) were searched from May 2017, the date of the last umbrella review on the subject, to September 2024. Eligible reviews reported population-level interventions in OECD countries, with outcomes stratified by socioeconomic status or related disadvantage. Included systematic reviews were appraised using AMSTAR II. We devised a conceptual Health Equity Pyramid that classified interventions by their agentic demand and population reach. Thirty-five systematic reviews were included. This review evaluated evidence across six policy domains. Redistributive and welfare interventions, including cash transfers, basic income and food subsidies, consistently improved food security, household financial stability and maternal–child health outcomes. Legislative and regulatory measures, such as smoke-free policies and pharmaceutical subsidy reforms, demonstrated robust population-level gains, particularly in disadvantaged groups. Community and housing interventions improved psychological health, reduced morbidity and mortality in targeted populations, and enhanced housing stability. Health system interventions, notably tailored smoking cessation and hospital discharge coordination for people experiencing homelessness, were effective in narrowing disparities. By contrast, educational and behavioural programmes and telehealth interventions often demanded high individual agency; without contextual tailoring, may exacerbate intervention-generated inequality. This umbrella review demonstrates that interventions characterised by low agentic demand: welfare reform, housing support, and legislative measures; yield the most consistent reductions in inequity. High agentic interventions can be effective when carefully tailored to disadvantaged populations but may otherwise exacerbate disparities. Future policy should prioritise structural, population-level strategies to achieve sustainable equity in health outcomes. CRD42024529176.